Why Core Scientific, Inc.’s (CORZ) Stock Is Down 7.14%
As of Thursday, October 15, Core Scientific, Inc.’s CORZ share price has dipped by 7.14%, which has investors questioning if this is right time to buy.Michael Rose
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
Michael Rose
Jenna Brashear
Rosalio Madrigal
Jenna Brashear
Cynthia McLaughlin
| Share Statistics | CORZ | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $4,412.0 | $937.8 | 66% |
|
| Shares Out (Mil) | 325.3 | 77.1 | 83% |
|
| Institutional Ownership | 98.4% | 82.2% | 78% |
|
| Float (Mil) | 292.9 | 54.2 | 79% |
|
| Beta | 5.48 | 1.04 | 100% |
|
| Avg Daily Volume (000s) | 16,529 | 626 | 98% |
|
| Price Change (52-week) |
(30.2%) | 58.3% | 30% |
|
| Growth | CORZ | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 39.5% | 14.8% | 93% |
|
| Net Income (5yr) | (88.3%) | 10.1% | 2% |
|
| EPS (5yr) | (43.7%) | 16.3% | 5 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | (178.3%) | (15.3%) | 0% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 4 | 3 | 4 | |
| Current EPS | ($0.004) | ($3.792) | $0.163 | |
| Month Ago EPS | ($0.040) | ($3.875) | $0.140 | |
| # Rev Up | 1 | 0 | 1 | |
| # Rev Down | 0 | 1 | 1 | |
| Three Months Ago EPS | ($0.055) | ($1.040) | $0.297 | |
| Year/Year Chg | (99.9%) | 329.4% | (143.5%) | |
| Financials | CORZ | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $440 | $345 | 39% |
|
| Net Income (TTM) (Mil) | ($1,431) | ($2) | 1% |
|
| EPS (TTM) | ($5.073) | ($0.100) | 8% |
|
| Operating Cash Flow (TTM) (Mil) | $520 | $34 | 72% |
|
| Net Cash Flow (TTM) (Mil) | $1,970 | $2 | 97% |
|
| Long-Term Debt (Q1) (Mil) | $4,394 | $34 | 84% |
|
| Enterprise Value (Q1) (Mil) | $8,537 | $1,084 | 71% |
|
| Valuation | CORZ | Industry Median |
Percentile (All Stocks) |
|
| P/B | na | 2.98 | na |
|
| P/E | na | 36.6 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 2.1 | na |
|
| Ratios | CORZ | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 32.1% | 70.4% | 38% |
|
| Net Margin | (324.9%) | 0.8% | 3% |
|
| ROA | (39.5%) | (1.2%) | 14% |
|
| ROE | 82.1% | 0.6% | 95% |
|
| Liabilities to Assets | 146.0% | 46.8% | 98% |
|
| F-Score | 4 | 5 | 33% |
|
Core Scientific, Inc. did not pass any screens on 10/19/2026.
Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.
Ⓒ 2026 American Association of Individual Investors